JP2010516747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010516747A5 JP2010516747A5 JP2009546785A JP2009546785A JP2010516747A5 JP 2010516747 A5 JP2010516747 A5 JP 2010516747A5 JP 2009546785 A JP2009546785 A JP 2009546785A JP 2009546785 A JP2009546785 A JP 2009546785A JP 2010516747 A5 JP2010516747 A5 JP 2010516747A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- mrp2
- protein
- ige
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20075059A FI20075059A0 (fi) | 2007-01-29 | 2007-01-29 | Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus |
| US88786207P | 2007-02-02 | 2007-02-02 | |
| US97788107P | 2007-10-05 | 2007-10-05 | |
| FI20075707A FI20075707A0 (fi) | 2007-10-05 | 2007-10-05 | Menetelmä uusien IgE-pohjaisten reagenssien valmistamiseksi |
| PCT/FI2008/050027 WO2008092993A1 (en) | 2007-01-29 | 2008-01-29 | Method for producing novel ige based reagents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010516747A JP2010516747A (ja) | 2010-05-20 |
| JP2010516747A5 true JP2010516747A5 (https=) | 2011-02-24 |
Family
ID=39673692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546785A Pending JP2010516747A (ja) | 2007-01-29 | 2008-01-29 | IgEを主成分とする新規試薬の製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100311604A1 (https=) |
| EP (1) | EP2115139B8 (https=) |
| JP (1) | JP2010516747A (https=) |
| AU (1) | AU2008211807B2 (https=) |
| CA (1) | CA2676843A1 (https=) |
| NZ (1) | NZ577858A (https=) |
| WO (1) | WO2008092993A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011156734A2 (en) | 2010-06-11 | 2011-12-15 | Hitachi Chemical Co., Ltd. | Method of characterizing vascular diseases |
| JP5755326B2 (ja) * | 2010-06-11 | 2015-07-29 | 日立化成株式会社 | 腎機能の特徴を決定する方法 |
| US9719129B2 (en) | 2011-06-10 | 2017-08-01 | Hitachi Chemical Co., Ltd. | Methods for isolating vesicles from biological fluids |
| WO2014003008A1 (ja) | 2012-06-28 | 2014-01-03 | 国立大学法人広島大学 | ヒト汗中に含まれる新規ヒスタミン遊離物質 |
| WO2014027626A1 (ja) | 2012-08-17 | 2014-02-20 | 国立大学法人広島大学 | 汗アレルギー抗原蛋白質に結合するモノクローナルIgE抗体 |
| JP6297676B2 (ja) | 2013-05-06 | 2018-03-20 | 日立化成株式会社 | 標的分子を捕捉するためのデバイス及び方法 |
| EP2820947A1 (en) * | 2013-07-05 | 2015-01-07 | B Cell Design | Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| US10370719B2 (en) | 2014-11-12 | 2019-08-06 | Hitachi Chemical Co., Ltd. | Method and device for diagnosing organ injury |
| DE112016003948T5 (de) | 2015-08-31 | 2018-05-09 | City Of Sapporo | Molekulare verfahren zum beurteilen einer urothelialen erkrankung |
| WO2017152088A1 (en) | 2016-03-04 | 2017-09-08 | JN Biosciences, LLC | Antibodies to tigit |
| CN110234352A (zh) * | 2017-01-31 | 2019-09-13 | Msm蛋白质技术公司 | 抗cxcr4抗体 |
| BR112022024221A2 (pt) | 2020-06-02 | 2022-12-20 | Arcus Biosciences Inc | Anticorpos para tigit |
| CN119626432B (zh) * | 2025-02-17 | 2025-05-27 | 杭州艾替捷英科技有限公司 | 针对宠物过敏源检测结果大数据的云架构聚类管理方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2059842A1 (en) * | 1991-02-11 | 1992-08-12 | Richard A. Chizzonite | Ige-receptor-antibodies |
| US5965709A (en) * | 1991-08-14 | 1999-10-12 | Genentech, Inc. | IgE antagonists |
| US6063621A (en) * | 1992-10-27 | 2000-05-16 | Queen's University At Kingston | Antibodies to a multidrug resistance protein |
| ZA966075B (en) * | 1995-07-27 | 1998-01-19 | Genentech Inc | Protein formulation. |
| US6299875B1 (en) * | 1998-06-04 | 2001-10-09 | Panacea Pharmaceuticals, Llc | Methods to block IGE binding to cell surface receptors of mast cells |
| FI112501B (fi) * | 2001-05-18 | 2003-12-15 | Valtion Teknillinen | Heveiiniä sitovat monoklonaaliset vasta-aineet |
| US7438907B2 (en) * | 2002-11-15 | 2008-10-21 | Genmab A/S | Human monoclonal antibodies against CD25 |
| JP2005024245A (ja) * | 2003-03-25 | 2005-01-27 | Rikogaku Shinkokai | Abcタンパク質と相互作用する物質のスクリーニング方法 |
| WO2005051299A2 (en) * | 2003-11-19 | 2005-06-09 | Dyax Corp. | Metalloproteinase-binding proteins |
-
2008
- 2008-01-29 AU AU2008211807A patent/AU2008211807B2/en not_active Ceased
- 2008-01-29 US US12/523,140 patent/US20100311604A1/en not_active Abandoned
- 2008-01-29 NZ NZ577858A patent/NZ577858A/en not_active IP Right Cessation
- 2008-01-29 JP JP2009546785A patent/JP2010516747A/ja active Pending
- 2008-01-29 CA CA002676843A patent/CA2676843A1/en not_active Abandoned
- 2008-01-29 WO PCT/FI2008/050027 patent/WO2008092993A1/en not_active Ceased
- 2008-01-29 EP EP08709296.1A patent/EP2115139B8/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010516747A5 (https=) | ||
| JP6900354B2 (ja) | 癌治療のための二重特異性her2リガンド | |
| AU2008211807B2 (en) | Method for producing novel IgE based reagents | |
| Pavlickova et al. | Advances in recombinant antibody microarrays | |
| CN105980407B (zh) | 单克隆抗tk1抗体 | |
| Wu et al. | Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules | |
| JP7695881B2 (ja) | 操作されたcd25ポリペプチドおよびその使用 | |
| DK2114996T3 (en) | A process for the preparation of hypo allergens | |
| JP2021193374A (ja) | リン酸化アルファ−シヌクレインを検出するための方法 | |
| JP2007526233A5 (https=) | ||
| Ebrahimizadeh et al. | Production of novel VHH nanobody inhibiting angiogenesis by targeting binding site of VEGF | |
| CN106164672B (zh) | 用于诊断的细胞表面前列腺癌抗原 | |
| Geng et al. | Structure-based design of peptides with high affinity and specificity to HER2 positive tumors | |
| Shukla et al. | Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies | |
| Figini et al. | Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor | |
| WO2022152185A1 (zh) | 靶向cd5的全人源抗体 | |
| Murray et al. | Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2 | |
| US7550268B2 (en) | Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders | |
| TWI454275B (zh) | T細胞之死亡誘導表位 | |
| Domina et al. | Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries | |
| Zahid et al. | Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential | |
| US20220162341A1 (en) | Methods of using monoclonal antibodies targeting epitopes of asph | |
| Ning et al. | An alternative strategy for high throughput generation and characterization of monoclonal antibodies against human plasma proteins using fractionated native proteins as immunogens | |
| Huang et al. | A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes | |
| Ballard et al. | Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling |